Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients

Por Macías, J, Mallolas, J, López-Cortés, LF, Cartón, JA, Domingo, P, Moreno, S, Iribarren, JA, Neukam, K, Rodrigo, A, Jiménez-Expósito, MJ, Pineda, JA
Publicado em 2010